Immunotherapy Revolutionizes NSCLC, But Unanswered Questions Remain – OncLive
OncLive |
Immunotherapy Revolutionizes NSCLC, But Unanswered Questions Remain
OncLive Immunotherapy has had a milestone impact in the field of non–small cell lung cancer (NSCLC). However, as more research unravels, investigators are unsure which set of combinations will likely have the most positive effect on their patients with … |
